The AI in drug discovery market was valued at USD 2.29 billion in 2025 and is expected to reach USD 2.85 billion in 2026 and USD 16.77 billion by 2034, expanding at a CAGR of 24.78% over the forecast period 2026–2034. Leading companies include Recursion Pharmaceuticals, Atomwise Inc., Insilico Medicine, Isomorphic Labs, Schrödinger, Owkin, XtalPi, insitro, BenevolentAI, Aitia,...